U.S. markets open in 7 hours 52 minutes

Amicus Therapeutics, Inc. (FOLD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.29-0.04 (-0.43%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close9.33
Open9.26
Bid0.00 x 3200
Ask0.00 x 4000
Day's Range9.19 - 9.45
52 Week Range8.60 - 25.39
Volume1,692,107
Avg. Volume2,468,820
Market Cap2.472B
Beta (5Y Monthly)1.12
PE Ratio (TTM)N/A
EPS (TTM)-0.97
Earnings DateAug 05, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est16.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Analysts Estimate Amicus Therapeutics (FOLD) to Report a Decline in Earnings: What to Look Out for
    Zacks

    Analysts Estimate Amicus Therapeutics (FOLD) to Report a Decline in Earnings: What to Look Out for

    Amicus Therapeutics (FOLD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021
    GlobeNewswire

    Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021

    PHILADELPHIA, July 27, 2021 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, August 5, 2021 at 8:30 a.m. ET to discuss financial results for the second quarter ended June 30, 2021. Interested participants and investors may access the conference call by dialing 877-303-5859 (U.S./Canada) or 678-224-7784 (international), conference ID: 7374935. A live audio webcast and related presentation materi

  • Here is What Hedge Funds Think About Amicus Therapeutics, Inc. (FOLD)
    Insider Monkey

    Here is What Hedge Funds Think About Amicus Therapeutics, Inc. (FOLD)

    As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade. Most investors who decided to stick with hedge funds after a rough 2018 recouped their losses by the end of the fourth quarter of 2019. A significant number of hedge funds continued their strong […]